Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Feb;118(3):353-61.
doi: 10.1111/j.1471-0528.2010.02807.x. Epub 2010 Dec 23.

Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial

N Mobeen  1 , J Durocher, Nf Zuberi, N Jahan, J Blum, S Wasim, G Walraven, J Hatcher
Affiliations
Free PMC article
Randomized Controlled Trial

Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial

N Mobeen et al. BJOG. 2011 Feb.
Free PMC article

Abstract

Objective: to determine if misoprostol is safe and efficacious in preventing postpartum haemorrhage (PPH) when administered by trained traditional birth attendants (TBA) at home deliveries.

Design: a randomised, double-blind, placebo-controlled trial.

Setting: Chitral, Khyber Pakhtunkhwa Province, Pakistan.

Population: a total of 1119 women giving birth at home.

Methods: from June 2006 to June 2008, consenting women were randomised to receive 600 microg oral misoprostol (n = 534) or placebo (n = 585) after delivery to determine whether misoprostol reduced the incidence of PPH (≥ 500 ml).

Main outcome measures: the primary outcomes were measured blood loss ≥ 500 ml after delivery and drop in haemoglobin >2 g/dl from before to after delivery.

Results: oral misoprostol was associated with a significant reduction in the rate of PPH (≥ 500 ml) (16.5 versus 21.9%; relative risk 0.76, 95% CI 0.59-0.97). There were no measurable differences between study groups for drop in haemoglobin >2 g/dl (relative risk 0.79, 95% CI 0.62-1.02); but significantly fewer women receiving misoprostol had a drop in haemoglobin >3 g/dl, compared with placebo (5.1 versus 9.6%; relative risk 0.53, 95% CI 0.34-0.83). Shivering and chills were significantly more common with misoprostol. There were no maternal deaths among participants.

Conclusions: postpartum administration of 600 microg oral misoprostol by trained TBAs at home deliveries reduces the rate of PPH by 24%. Given its ease of use and low cost, misoprostol could reduce the burden of PPH in community settings where universal oxytocin prophylaxis is not feasible. Continual training and skill-building for TBAs, along with monitoring and evaluation of programme effectiveness, should accompany any widespread introduction of this drug.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT flow diagram: trial profile.
Figure 2
Figure 2
Rates of PPH (≥500 and ≥1000 ml) for two sequential subgroups of women randomised to receive misoprostol or placebo.
Figure 3
Figure 3
Rates of Hb drop pre- to post-delivery (>2 and >3 g/dl) for two sequential subgroups of women randomised to receive misoprostol or placebo.
See this image and copyright information in PMC

Comment in

References

    1. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet. 2006;367:1066–74. - PubMed
    1. Ramanathan G, Arulkumaran S. Postpartum haemorrhage. J Obstet Gynaecol Can. 2006;28:967–73. - PubMed
    1. AbouZahr C. Global burden of maternal death and disability. Br Med Bull. 2003;67:1–11. - PubMed
    1. United Nations. The millennium development goals report 2009 [Online] 2009. [ http://www.un.org/millenniumgoals/pdf/MDG%20Report%202009%20ENG.pdf]. Last accessed 26 July 2009.
    1. National Institute of Population Studies (NIPS) [Pakistan], Macro International Inc. Pakistan Demographic and Health Survey 2006–07. Islamabad, Pakistan: National Institute of Population Studies and Macro International Inc.; 2008.

Publication types